Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Vose

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphomaT E Witzig, J M Vose, P L Zinzani, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomasM S Kaminski, A D Zelenetz, O W Press, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphomaD D Weisenburger, R D Gascoyne, P J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignanciesZ S Pavletic, M R Bishop, S R Tarantolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factorM R Bishop, S R Tarantolo, J D Jackson, et al.
Bone Marrow Transplantation|March 5, 1998
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesZ S Pavletic, S S Joshi, S J Pirruccello, et al.
Cytotherapy|December 9, 2003
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind studyS S Joshi, M R Bishop, J C Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryH M Lazarus, P A Rowlings, M J Zhang, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphomaT E Witzig, J M Vose, P L Zinzani, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomasM S Kaminski, A D Zelenetz, O W Press, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphomaD D Weisenburger, R D Gascoyne, P J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignanciesZ S Pavletic, M R Bishop, S R Tarantolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factorM R Bishop, S R Tarantolo, J D Jackson, et al.
Bone Marrow Transplantation|March 5, 1998
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesZ S Pavletic, S S Joshi, S J Pirruccello, et al.
Cytotherapy|December 9, 2003
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind studyS S Joshi, M R Bishop, J C Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryH M Lazarus, P A Rowlings, M J Zhang, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 14